A Search for the “Multiple Sclerosis Virus” — Lack of Effect of Brain Extracts on Myelin Development in Chickens, Mice and Rats

  • N. R. Sims
  • C. C. A. Bernard
  • L. Horvath
  • I. R. Mackay
  • P. R. Carnegie
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 100)


Attempts were made to transmit possible infectious agents from tissue of MS patients into three animal species, under conditions designed to enhance the development of such an agent. Myelination was monitored by measuring CNPase activity and myelin basic protein. Although no significant effects were observed, the usefulness of a new assay for CNPase was demonstrated. Nude mice were found to have a lower level of CNPase than their heterozygous littermates.


Multiple Sclerosis Myelin Basic Protein Cyclic Nucleotide Brain Homogenate Control Material 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brown, P. and Gajdusek, D.C., No mouse PMN leukocyte depression after inoculation with brain tissue from multiple sclerosis or spongiform encephalopathies, Nature 247 (1974) 217–218.PubMedCrossRefGoogle Scholar
  2. 2.
    Carp, R.I., Licursi, P.C., Merz, P.A. and Merz, G.S., Decreased percentage of polymorphonuclear neutrophils in mouse peripheral blood after inoculation with material from multiple sclerosis patients, J. Exp. Med. 136 (1972) 618–629.PubMedCrossRefGoogle Scholar
  3. 3.
    Cohen, S.R., McKhann, G.M. and Guarnieri, M., A radioimmunoassay for myelin basic protein and its use for quantitative measurements, J. Neurochem. 25 (1975) 371–376.PubMedCrossRefGoogle Scholar
  4. 4.
    Fraser, K.B., Multiple sclerosis: a virus disease ? Br. Med. Bull. 33 (1977) 34–39.PubMedGoogle Scholar
  5. 5.
    Henle, G.,Koldovsky, U., Henle, W., Ackermann, R. and Haase, G., Multiple sclerosis-associated agent: neutralization of the agent by human sera, Inf. Imm. 12 (1975) 1367–1374.Google Scholar
  6. 6.
    Koldovsky, U., Koldovsky, P., Henle, G., Henle, W., Ackermann, R. and Haase, G., Multiple sclerosis-associated agent: transmission to animals and some properties of the agent, Inf. Imm. 12 (1975) 1355–1366.Google Scholar
  7. 7.
    Komiya, Y. and Kasahara, M., 2’,3’-cyclic nucleotide 3’phosphohydrolase activity in myelin fractions from one patient with Schilder’s disease, J. Biochem. 70 (1971) 371–374.PubMedGoogle Scholar
  8. 8.
    Kristensson, K., Olsson, Y. and Sourander, P., Virus encephalitis: pathogenesis in the immature brain, Develop. Med. Child Neurol. 16 (1974) 382–394.PubMedCrossRefGoogle Scholar
  9. 9.
    Kurihara, T., Nussbaum, J.L. and Mandel, P., 2’,3’-cyclic nucleotide 3’-phosphohydrolase in brains of mutant mice with deficient myelination, J. Neurochem. 17 (1970) 993–997.PubMedCrossRefGoogle Scholar
  10. 10.
    Kurihara, T. and Tsukada, Y., 2’,3’-cyclic nucleotide 3’phosphohydrolase in the developing chick brain and spinal cord, J. Neurochem. 15 (1968) 827–832.PubMedCrossRefGoogle Scholar
  11. 11.
    Lees, M.B. and Paxman, S., Modification of the Lowry procedure for the analysis of proteolipid protein, Analyt. Biochem. 47 (1972) 184–192.PubMedCrossRefGoogle Scholar
  12. 12.
    Licursi, P.C., Merz, P.A., Merz, G.S. and Carp, R.I., Scrapieinduced changes in the percentage of polymorphonuclear neutrophils in mouse peripheral blood, Inf. Imm. 6 (1972) 370–376.Google Scholar
  13. 13.
    Lipton, H.L. and Dal Canto, M.C., Theiler’s virus-induced demyelination: prevention by immunosuppression, Science 192 (1976) 62–64.PubMedCrossRefGoogle Scholar
  14. 14.
    Lumsden, C.E., The clinical pathology of multiple sclerosis, in Multiple Sclerosis, a Reappraisal ( D. McAlpine, C.E. Lumsden and E.D. Acheson, eds.) Churchill, Livingstone, Edinburgh (1972) pp. 311–621.Google Scholar
  15. 15.
    McNeill, T.A., Killen, M. and Trudgett, A., Mouse granulocyte precursors and multiple sclerosis, Nature 249 (1974) 778.PubMedCrossRefGoogle Scholar
  16. 16.
    Madden, D.L., Kreslewicz, A., Gravell, M. and Sever, J.L., Multiple sclerosis associated agent: failure to confirm an association, Neurology 27 (1977) 371.CrossRefGoogle Scholar
  17. 17.
    Nakhasi, H.L., Toews, A.D. and Horrocks, L.A., Effects of a postnatal protein deficiency on the content and composition of myelin from brains of weanling rats, Brain Res. 83 (1975) 176–179.CrossRefGoogle Scholar
  18. 18.
    Riekkinen, P.J., Rinne, U.K., Arstila, A.U., Kurihara, T. and Pelliniemi, T.T., Studies on the pathogenesis of multiple sclerosis: 2’,3’-cyclic nucleotide 3’-phosphohydrolase as marker of demyelination and correlation of findings with lysosomal changes, J. Neurol. Sci. 15 (1972) 113–120.PubMedCrossRefGoogle Scholar
  19. 19.
    Russell, E.S., Neufeld, E.F. and Higgins, C.T., Comparison of normal blood picture of young adults from 18 inbred strains of mice, Proc. Soc. Exp. Biol. Med. 78 (1951) 761–766.PubMedGoogle Scholar
  20. 20.
    Rygaard, J., Thymus and self, Immunobiology of the mouse mutant nude (1973) F.A.D.L. Copenhagen.Google Scholar
  21. 21.
    Sever, J.L., Fuccillo, D.A., Madden, D.L. and Castellano, G.A., Multiple sclerosis: attempts to demonstrate altered immune responses and viruses, Neurology 26 (6, part 2) (1976) 72–74.PubMedCrossRefGoogle Scholar
  22. 22.
    Sims, N.R. and Carnegie, P.R., A rapid assay for 2’,3’-cyclic nucleotide 3’-phosphohydrolase, J.Neurochem. 27 (1976) 769–772.PubMedCrossRefGoogle Scholar
  23. 23.
    Sims,N.R. and Carnegie, P.R., 2’,3’-cyclic nucleotide 3’phosphodiesterase, Advances in Neurochem. 3 (1977) in press.Google Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • N. R. Sims
    • 1
  • C. C. A. Bernard
    • 2
  • L. Horvath
    • 1
  • I. R. Mackay
    • 2
  • P. R. Carnegie
    • 1
  1. 1.Russell Grimwade School of BiochemistryUniversity of MelbourneParkvilleAustralia
  2. 2.Walter and Eliza Hall Institute of Medical ResearchParkvilleAustralia

Personalised recommendations